Fundraising FoxVida Ventures — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs.
BiotechDigital HealthMedical Devices
Co-investorsYsios CapitalHealthCapJeito Capital
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Co-investorsLeaps by BayerARCH Venture PartnersFoothill VenturesIllumina VenturesMedical Excellence CapitalVivo Capital+8 more
ByHeart is an infant formula company that manufactures science-driven baby formula with its own manufacturing process and supply chain.
ConsumerDirect to ConsumerFoodTechHealthtechNew York, US
Ron Belldegrun(Co-founder)inMia Funt(Founder)inGeorg Krause-Vilmar(Executive Officer)inNiall Mullane(Executive Officer)in
BoardAmy Schulman(Director)Hemi Zucker(Director)in
Board seatArie BelldegrunJoshua Kazam· per SEC Form D
Co-investorsEvolution VC PartnersGaingelsOCV PartnersRed Sea VenturesAF VenturesPolaris Partners
__Twitter.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.